L-Loc Injection
Images are for reference. Actual packaging may vary.
Terlipressin (1mg)
Vial of 10 ml • Liquid
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Terlipressin activates V1 receptors on vascular smooth muscle, causing vasoconstriction and reducing portal pressure, which helps control bleeding from esophageal varices.
Medical applications
L-Loc Injection contains Terlipressin 1mg, a synthetic vasopressin analogue used primarily for the management of conditions associated with portal hypertension, such as esophageal variceal bleeding and hepatorenal syndrome. Terlipressin acts as a vasoconstrictor by selectively binding to vasopressin V1 receptors on vascular smooth muscle, leading to constriction of splanchnic blood vessels and a consequent reduction in portal venous pressure.
This mechanism helps control acute variceal hemorrhage and improves renal perfusion in hepatorenal syndrome by redistributing blood flow. L-Loc Injection is administered intravenously under strict medical supervision, with dosage tailored according to the severity of the condition and patient response. Common adverse effects may include abdominal cramps, hypertension, headache, and peripheral ischemia, necessitating careful monitoring during therapy.
Contraindications include ischemic heart disease, peripheral vascular disease, and hypersensitivity to Terlipressin or any excipients. L-Loc Injection should be used with caution in patients with cardiovascular disorders or electrolyte imbalances. It is essential to adhere to recommended dosing regimens and monitor vital signs and laboratory parameters to optimize therapeutic outcomes and minimize potential risks.
This product is intended for hospital use and should be handled by healthcare professionals trained in its administration.
Vasopressin analogues
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
L-Loc Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Information regarding the use of L-Loc Injection during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of L-Loc Injection in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether L-Loc Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of L-Loc Injection in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for L-Loc Injection




